Failure in drug safety assessment: a worrying issue far beyond manufacturer’s potential conflicts of interest

Statins This paper is currently submitted. In a 20-year old communication, I asked whether post-marketing surveillance was “an art or a science”: no doubt, twenty years later, that drug monitoring is just playacting, which may evolve in tragedies. Analysis of the statin story (amongst others) comes to the sad conclusion…

Hepatitis B universal vaccination: learning from the French experience

Hepatitis B vaccine This update has been written for the numerous prescribers and health professionals who are logically disturbed by a growing discrepancy between the recommendation they are receiving of protecting public heath by hepatitis B vaccination and an accumulation of alarming data on the hazards of this prophylaxis.Focused on…

Report criticizes French hepatitis B vaccination campaign

Hepatitis B vaccine http://www.medscape.com/viewarticle/444869 ou http://www.vaccinetruth.org/france1.htm A report ordered by Judge MO Bertella-Geffroy, currently presiding over a negligence case brought by the familes of people - some of them have died - who developed neurological problems after hepatitis B vaccination. Report Criticizes French Hepatitis VaccinationCampaign PARIS (Reuters Health) Nov 20…